- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06190964
Integrative Medicine for Hospital Workers Exposed to War
Assessing the Impact of Integrative Medicine on Anxiety and Wellbeing of Hospital Workers Exposed Directly or Indirectly to Terror, Trauma or War
During the "Iron Swords" war in Israel in 2023, the residents of the Gaza Strip and the surrounding area, along with the soldiers of the security service, were exposed to a very high intensity of trauma. Added to this is an extensive cycle of trauma for those who were directly and indirectly exposed to loss and terror throughout the country. Medical teams in the hospitals and in the community were exposed with the highest intensity to these traumatic aspects which were amplified by the collapse of many of the resilience and mental health centers in the south.
An integrative medicine treatment clinic was established at the Bnai Zion Medical Center for the purpose of providing a response to all hospital employees who are exposed and will be exposed (directly or indirectly) to the wounded and patients expressing trauma, including symptoms of acute stress disorder, as a result of war and terrorism. Hospital employees are invited to register for complementary medicine treatments on the hospital's website according to indications that include anxiety, emotional distress and/or typical Acute Stress Disorder (ASD) symptoms, including physical distress (such as pain, breathing disorder, digestive system symptoms, exhaustion, etc.). The employees are treated by a team from the system for integrative medicine, including practitioners of acupuncture; touch/movement techniques (for example, qigong, reflexology, shiatsu) or mind-body medicine (for example, relaxation and breathing exercises) and may include one or more of the above 3 treatment areas.
In the proposed study, the investigators plan to examine the effect of these treatments on various symptoms experienced by hospital employees during this period.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Samuel Attias, PhD
- Phone Number: 972-52-4707304
- Email: samuel.attias@b-zion.org.il
Study Locations
-
-
-
Haifa, Israel, 3339419
- Recruiting
- Bnai Zion Medical Center
-
Contact:
- Miriam Goldberg
- Phone Number: 972-50-6432872
- Email: miriam.goldberg@b-zion.org.il
-
Principal Investigator:
- Samuel Attias, PhD
-
Sub-Investigator:
- Ilana Levy Yurkovski, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hospital employees
- Anxiety, emotional distress and/or typical ASD symptoms directly or indirectly related to exposure to the trauma of terrorism or war
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Integrative medicine
The employees are treated by a team from the system for integrative medicine, including practitioners of acupuncture; touch/movement techniques (for example, qigong, reflexology, shiatsu) or mind-body medicine (for example, relaxation and breathing exercises) and may include one or more of the above 3 treatment areas.
|
Acupuncture; touch/movement techniques (for example, qigong, reflexology, shiatsu) and/or mind-body medicine (for example, relaxation and breathing exercises)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptom relief
Time Frame: Before intervention; 24 hours after intervention
|
Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire: minimum value: 0; maximum value: 6; higher score means worse outcome.
|
Before intervention; 24 hours after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stress and anxiety
Time Frame: Before intervention; 4 to 8 weeks after intervention
|
Acute Stress Disorder (ASD) questionnaire: minimum value: 0; maximum value: 63; higher score means worse outcome.
|
Before intervention; 4 to 8 weeks after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Samuel Attias, PhD, Complementary Medicine Service
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0105-23-BNZ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.